CD8A and breast carcinoma: Moreover, studies have highlighted that tumor-resident memory CD8+ T cells with a structured residency phenotype are associated with favorable prognoses in patients with triple-negative breast cancer and play significant roles in the efficacy of checkpoint blockade therapies and sustaining protective immunity against breast cancer [40].